189 related articles for article (PubMed ID: 21680707)
21. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
22. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
23. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
25. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
[TBL] [Abstract][Full Text] [Related]
26. Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk.
Liu CR; Li Q; Hou C; Li H; Shuai P; Zhao M; Zhong XR; Xu ZP; Li JY
DNA Cell Biol; 2018 Mar; 37(3):182-188. PubMed ID: 29336592
[TBL] [Abstract][Full Text] [Related]
27. Plasma matrix metalloproteinase 2 levels and breast cancer risk.
Aroner SA; Rosner BA; Tamimi RM; Tworoger SS; Baur N; Joos TO; Hankinson SE
Cancer Epidemiol; 2015 Jun; 39(3):321-7. PubMed ID: 25799912
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
29. [Population-based Study of the Effects of Adiponectin, Leptin and Soluble Leptin Receptor on Risks for Breast Cancer].
Yi F; Xu B; Diao S; Hou C; Li JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):259-266. PubMed ID: 33829700
[TBL] [Abstract][Full Text] [Related]
30. Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer.
Rodrigo C; Tennekoon KH; Karunanayake EH; De Silva K; Amarasinghe I; Wijayasiri A
Endocr J; 2017 Apr; 64(4):393-401. PubMed ID: 28190851
[TBL] [Abstract][Full Text] [Related]
31. Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.
Sun Q; van Dam RM; Meigs JB; Franco OH; Mantzoros CS; Hu FB
Diabetes; 2010 Mar; 59(3):611-8. PubMed ID: 19959759
[TBL] [Abstract][Full Text] [Related]
32. Body shape throughout life and correlations with IGFs and GH.
Schernhammer ES; Tworoger SS; Eliassen AH; Missmer SA; Holly JM; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102
[TBL] [Abstract][Full Text] [Related]
33. Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
Aleksandrova K; Boeing H; Jenab M; Bueno-de-Mesquita HB; Jansen E; van Duijnhoven FJ; Rinaldi S; Fedirko V; Romieu I; Riboli E; Gunter MJ; Westphal S; Overvad K; Tjønneland A; Halkjær J; Racine A; Boutron-Ruault MC; Clavel-Chapelon F; Kaaks R; Lukanova A; Trichopoulou A; Lagiou P; Trichopoulos D; Mattiello A; Pala V; Palli D; Tumino R; Vineis P; Buckland G; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Menéndez V; Peeters PH; Söderberg S; Palmqvist R; Allen NE; Crowe FL; Khaw KT; Wareham N; Pischon T
Cancer Res; 2012 Oct; 72(20):5328-37. PubMed ID: 22926557
[TBL] [Abstract][Full Text] [Related]
34. Plasma adiponectin concentrations and risk of incident breast cancer.
Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
[TBL] [Abstract][Full Text] [Related]
35. Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
Wang Y; Gapstur SM; Gaudet MM; Furtado JD; Campos H; McCullough ML
Cancer Causes Control; 2015 Sep; 26(9):1233-44. PubMed ID: 26081425
[TBL] [Abstract][Full Text] [Related]
36. Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II.
Kotsopoulos J; McGee EE; Lozano-Esparza S; Garber JE; Ligibel J; Collins LC; Polyak K; Brown M; Narod S; Tamimi RM; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1264-1270. PubMed ID: 32277005
[TBL] [Abstract][Full Text] [Related]
37. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
38. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
39. Plasma leptin and breast cancer risk: a prospective study in northern Sweden.
Stattin P; Söderberg S; Biessy C; Lenner P; Hallmans G; Kaaks R; Olsson T
Breast Cancer Res Treat; 2004 Aug; 86(3):191-6. PubMed ID: 15567935
[TBL] [Abstract][Full Text] [Related]
40. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study.
Baer HJ; Colditz GA; Rosner B; Michels KB; Rich-Edwards JW; Hunter DJ; Willett WC
Breast Cancer Res; 2005; 7(3):R314-25. PubMed ID: 15987426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
